Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors

Clinical trial NCT02644291 · COMPLETED

Trial details

NCT number: NCT02644291
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Medulloblastoma Astrocytoma, Grade III Glioblastoma Anaplastic Astrocytoma Brain Stem Neoplasms, Malignant Oligodendroblastoma Anaplastic Oligodendroglioma Malignant Glioma

Start date: 2016-05-01
Primary completion: 2022-06-09
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.